Clinical Trial Update: Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating botulinum toxin type A (Botox) for Cervical Dystonia and refractory cervicothoracic myofascial pain syndrome has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia
• Myofascial Pain Syndrome

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Vanderbilt University | Conditions: Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS), Cervical Dystonia | Phase 1, Phase 2 | Status: COMPLETED